{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:11:37Z","timestamp":1769764297798,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00430-018-0543-4","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T11:55:39Z","timestamp":1524743739000},"page":"227-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Influence of sphingosine-1-phosphate signaling on HCMV replication in human embryonal lung fibroblasts"],"prefix":"10.1007","volume":"207","author":[{"given":"Anika","family":"Zilch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Rien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Huskobla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Sauerbrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Gr\u00e4ler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5298-4409","authenticated-orcid":false,"given":"Andreas","family":"Henke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"issue":"4","key":"543_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","volume":"17","author":"JA Fishman","year":"2017","unstructured":"Fishman JA (2017) Infection in organ transplantation. Am J Transpl 17(4):856\u2013879","journal-title":"Am J Transpl"},{"issue":"1","key":"543_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12879-017-2599-y","volume":"17","author":"LA Selvey","year":"2017","unstructured":"Selvey LA, Lim WH, Boan P, Swaminathan R, Slimings C, Harrison AE, Chakera A (2017) Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience. BMC Infect Dis 17(1):501","journal-title":"BMC Infect Dis"},{"issue":"3","key":"543_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1034\/j.1399-3062.2003.00023.x","volume":"5","author":"EF Maar de","year":"2003","unstructured":"de Maar EF, Verschuuren EA, Harmsen MC, The TH, van Son WJ (2003) Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients. Transpl Infect Dis 5(3):112\u2013120","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"543_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/0885066613476454","volume":"29","author":"G Travi","year":"2014","unstructured":"Travi G, Pergam SA (2014) Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med 29(4):200\u2013212","journal-title":"J Intensive Care Med"},{"issue":"4","key":"543_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ccm.2005.06.013","volume":"26","author":"MG Ison","year":"2005","unstructured":"Ison MG, Fishman JA (2005) Cytomegalovirus pneumonia in transplant recipients. Clin Chest Med 26(4):691\u2013705 viii.","journal-title":"Clin Chest Med"},{"issue":"10","key":"543_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a009384","volume":"147","author":"JR Murph","year":"1998","unstructured":"Murph JR, Souza IE, Dawson JD, Benson P, Petheram SJ, Pfab D, Gregg A, O\u2019Neill ME, Zimmerman B, Bale JF Jr (1998) Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol 147(10):940\u2013947","journal-title":"Am J Epidemiol"},{"issue":"4","key":"543_CR7","first-page":"S6\u201310","volume":"46","author":"MJ Cannon","year":"2009","unstructured":"Cannon MJ (2009) Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 46(4):S6\u201310","journal-title":"J Clin Virol"},{"issue":"2","key":"543_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jmv.2208","volume":"67","author":"AL Bissinger","year":"2002","unstructured":"Bissinger AL, Sinzger C, Kaiserling E, Jahn G (2002) Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol 67(2):200\u2013206","journal-title":"J Med Virol"},{"issue":"Suppl 4","key":"543_CR9","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jcv.2009.09.026","volume":"46","author":"L Gabrielli","year":"2009","unstructured":"Gabrielli L, Bonasoni MP, Lazzarotto T, Lega S, Santini D, Foschini MP, Guerra B, Baccolini F, Piccirilli G, Chiereghin A, Petrisli E, Gardini G, Lanari M, Landini MP (2009) Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 46(Suppl 4):S16\u201321","journal-title":"J Clin Virol"},{"issue":"8","key":"543_CR10","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/jmv.24484","volume":"88","author":"K Dulal","year":"2016","unstructured":"Dulal K, Cheng T, Yang L, Wang W, Huang Y, Silver B, Selariu A, Xie C, Wang D, Espeseth A, Lin Y, Wen L, Xia N, Fu TM, Zhu H (2016) Functional analysis of human cytomegalovirus UL\/b\u2019 region using SCID-hu mouse model. J Med Virol 88(8):1417\u20131426","journal-title":"J Med Virol"},{"issue":"23","key":"543_CR11","doi-asserted-by":"publisher","first-page":"12795","DOI":"10.1128\/JVI.01054-12","volume":"86","author":"E Maidji","year":"2012","unstructured":"Maidji E, Kosikova G, Joshi P, Stoddart CA (2012) Impaired surfactant production by alveolar epithelial cells in a SCID-hu lung mouse model of congenital human cytomegalovirus infection. J Virol 86(23):12795\u201312805","journal-title":"J Virol"},{"issue":"9","key":"543_CR12","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1128\/JVI.67.9.5360-5366.1993","volume":"67","author":"M Balthesen","year":"1993","unstructured":"Balthesen M, Messerle M, Reddehase MJ (1993) Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67(9):5360\u20135366","journal-title":"J Virol"},{"issue":"2","key":"543_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/JVI.55.2.264-273.1985","volume":"55","author":"MJ Reddehase","year":"1985","unstructured":"Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski UH (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55(2):264\u2013273","journal-title":"J Virol"},{"issue":"16","key":"543_CR14","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1128\/JVI.74.16.7496-7507.2000","volume":"74","author":"J Podlech","year":"2000","unstructured":"Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74(16):7496\u20137507","journal-title":"J Virol"},{"issue":"Pt 4","key":"543_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1099\/0022-1317-76-4-741","volume":"76","author":"C Sinzger","year":"1995","unstructured":"Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G (1995) Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76(Pt 4):741\u2013750","journal-title":"J Gen Virol"},{"key":"543_CR16","first-page":"63","volume":"325","author":"C Sinzger","year":"2008","unstructured":"Sinzger C, Digel M, Jahn G (2008) Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63\u201383","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"543_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/tid.12507","volume":"18","author":"JG Timpone","year":"2016","unstructured":"Timpone JG, Yimen M, Cox S, Teran R, Ajluni S, Goldstein D, Fishbein T, Kumar PN, Matsumoto C (2016) Resistant cytomegalovirus in intestinal and multivisceral transplant recipients. Transpl Infect Dis 18(2):202\u2013209","journal-title":"Transpl Infect Dis"},{"issue":"23","key":"543_CR18","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","volume":"128","author":"F Chaer El","year":"2016","unstructured":"El Chaer F, Shah DP, Chemaly RF (2016) How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood 128(23):2624\u20132636","journal-title":"Blood"},{"issue":"10","key":"543_CR19","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2217\/fmb.15.82","volume":"10","author":"KE Hanson","year":"2015","unstructured":"Hanson KE, Swaminathan S (2015) Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management. Future Microbiol 10(10):1545\u20131548","journal-title":"Future Microbiol"},{"issue":"2","key":"543_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.virol.2011.12.010","volume":"424","author":"D Kagele","year":"2012","unstructured":"Kagele D, Rossetto CC, Tarrant MT, Pari GS (2012) Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt. Virology 424(2):106\u2013114","journal-title":"Virology"},{"issue":"12","key":"543_CR21","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1371\/journal.ppat.0020132","volume":"2","author":"J Munger","year":"2006","unstructured":"Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD (2006) Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2(12):e132","journal-title":"PLoS Pathog"},{"issue":"10","key":"543_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/nbt.1500","volume":"26","author":"J Munger","year":"2008","unstructured":"Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26(10):1179\u20131186","journal-title":"Nat Biotechnol"},{"issue":"1","key":"543_CR23","doi-asserted-by":"publisher","first-page":"e1002502","DOI":"10.1371\/journal.ppat.1002502","volume":"8","author":"J McArdle","year":"2012","unstructured":"McArdle J, Moorman NJ, Munger J (2012) HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication. PLoS Pathog 8(1):e1002502","journal-title":"PLoS Pathog"},{"issue":"6\u20137","key":"543_CR24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1515\/hsz-2014-0273","volume":"396","author":"J Schneider-Schaulies","year":"2015","unstructured":"Schneider-Schaulies J, Schneider-Schaulies S (2015) Sphingolipids in viral infection. Biol Chem 396(6\u20137):585\u2013595","journal-title":"Biol Chem"},{"issue":"7503","key":"543_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka M, Spiegel S (2014) Sphingolipid metabolites in inflammatory disease. Nature 510(7503):58\u201367","journal-title":"Nature"},{"issue":"1","key":"543_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000362992","volume":"34","author":"AV Thuy","year":"2014","unstructured":"Thuy AV, Reimann CM, Hemdan NY, Graler MH (2014) Sphingosine 1-phosphate in blood: function, metabolism, and fate. Cell Physiol Biochem 34(1):158\u2013171","journal-title":"Cell Physiol Biochem"},{"issue":"2\u20133","key":"543_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","volume":"1585","author":"M Maceyka","year":"2002","unstructured":"Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585(2\u20133):193\u2013201","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"543_CR28","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1172\/JCI76369","volume":"125","author":"RL Proia","year":"2015","unstructured":"Proia RL, Hla T (2015) Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest 125(4):1379\u20131387","journal-title":"J Clin Invest"},{"key":"543_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fonc.2016.00218","volume":"6","author":"YI Rodriguez","year":"2016","unstructured":"Rodriguez YI, Campos LE, Castro MG, Aladhami A, Oskeritzian CA, Alvarez SE (2016) Sphingosine-1 phosphate: a new modulator of immune plasticity in the tumor microenvironment. Front Oncol 6:218","journal-title":"Front Oncol"},{"issue":"38","key":"543_CR30","doi-asserted-by":"publisher","first-page":"26148","DOI":"10.1074\/jbc.M710181200","volume":"283","author":"NJ Machesky","year":"2008","unstructured":"Machesky NJ, Zhang G, Raghavan B, Zimmerman P, Kelly SL, Merrill AH Jr, Waldman WJ, Van Brocklyn JR, Trgovcich J (2008) Human cytomegalovirus regulates bioactive sphingolipids. J Biol Chem 283(38):26148\u201326160","journal-title":"J Biol Chem"},{"issue":"21","key":"543_CR31","doi-asserted-by":"publisher","first-page":"14839","DOI":"10.1074\/jbc.M112.426726","volume":"288","author":"K Sobel","year":"2013","unstructured":"Sobel K, Menyhart K, Killer N, Renault B, Bauer Y, Studer R, Steiner B, Bolli MH, Nayler O, Gatfield J (2013) Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. J Biol Chem 288(21):14839\u201314851","journal-title":"J Biol Chem"},{"issue":"50","key":"543_CR32","doi-asserted-by":"publisher","first-page":"18153","DOI":"10.1073\/pnas.0509201102","volume":"102","author":"D Wang","year":"2005","unstructured":"Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 102(50):18153\u201318158","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"543_CR33","doi-asserted-by":"publisher","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","volume":"79","author":"D Wang","year":"2005","unstructured":"Wang D, Shenk T (2005) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79(16):10330\u201310338","journal-title":"J Virol"},{"issue":"3","key":"543_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00430-015-0411-4","volume":"204","author":"GW Wilkinson","year":"2015","unstructured":"Wilkinson GW, Davison AJ, Tomasec P, Fielding CA, Aicheler R, Murrell I, Seirafian S, Wang EC, Weekes M, Lehner PJ, Wilkie GS, Stanton RJ (2015) Human cytomegalovirus: taking the strain. Med Microbiol Immunol 204(3):273\u2013284","journal-title":"Med Microbiol Immunol"},{"issue":"5","key":"543_CR35","doi-asserted-by":"publisher","first-page":"e1001344","DOI":"10.1371\/journal.ppat.1001344","volume":"7","author":"N Renzette","year":"2011","unstructured":"Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF (2011) Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 7(5):e1001344","journal-title":"PLoS Pathog"},{"issue":"1","key":"543_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/mec.13331","volume":"25","author":"N Renzette","year":"2016","unstructured":"Renzette N, Kowalik TF, Jensen JD (2016) On the relative roles of background selection and genetic hitchhiking in shaping human cytomegalovirus genetic diversity. Mol Ecol 25(1):403\u2013413","journal-title":"Mol Ecol"},{"issue":"4","key":"543_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4330\/wjc.v5.i4.75","volume":"5","author":"M Kawabori","year":"2013","unstructured":"Kawabori M, Kacimi R, Karliner JS, Yenari MA (2013) Sphingolipids in cardiovascular and cerebrovascular systems: pathological implications and potential therapeutic targets. World J Cardiol 5(4):75\u201386","journal-title":"World J Cardiol"},{"issue":"19","key":"543_CR38","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.1128\/JVI.01877-14","volume":"88","author":"LA Ford Siltz","year":"2014","unstructured":"Ford Siltz LA, Viktorova EG, Zhang B, Kouiavskaia D, Dragunsky E, Chumakov K, Isaacs L, Belov GA (2014) New small-molecule inhibitors effectively blocking picornavirus replication. J Virol 88(19):11091\u201311107","journal-title":"J Virol"},{"issue":"2","key":"543_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","volume":"35","author":"Z Lou","year":"2014","unstructured":"Lou Z, Sun Y, Rao Z (2014) Current progress in antiviral strategies. Trends Pharmacol Sci 35(2):86\u2013102","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"543_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1074\/jbc.M004392200","volume":"276","author":"R Heller","year":"2001","unstructured":"Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER (2001) L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276(1):40\u201347","journal-title":"J Biol Chem"},{"issue":"14","key":"543_CR41","doi-asserted-by":"publisher","first-page":"10638","DOI":"10.1074\/jbc.M110.108688","volume":"285","author":"N Stahmann","year":"2010","unstructured":"Stahmann N, Woods A, Spengler K, Heslegrave A, Bauer R, Krause S, Viollet B, Carling D, Heller R (2010) Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J Biol Chem 285(14):10638\u201310652","journal-title":"J Biol Chem"},{"issue":"3","key":"543_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3181\/00379727-84-20714","volume":"84","author":"WP Rowe","year":"1953","unstructured":"Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84(3):570\u2013573","journal-title":"Proc Soc Exp Biol Med"},{"issue":"9","key":"543_CR43","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1172\/JCI42955","volume":"120","author":"RJ Stanton","year":"2010","unstructured":"Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, Seirafian S, McSharry BP, Neale ML, Davies JA, Tomasec P, Davison AJ, Wilkinson GW (2010) Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest 120(9):3191\u20133208","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"543_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1099\/vir.0.83286-0","volume":"89","author":"C Sinzger","year":"2008","unstructured":"Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, Messerle M, Hengel H, Koszinowski U, Brune W, Adler B (2008) Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40\/E. J Gen Virol 89(Pt 2):359\u2013368","journal-title":"J Gen Virol"},{"key":"543_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","volume":"11","author":"MV Berridge","year":"2005","unstructured":"Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127\u2013152","journal-title":"Biotechnol Annu Rev"},{"issue":"6","key":"543_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00430-015-0391-4","volume":"204","author":"E Ammer","year":"2015","unstructured":"Ammer E, Nietzsche S, Rien C, Kuhnl A, Mader T, Heller R, Sauerbrei A, Henke A (2015) The anti-obesity drug orlistat reveals anti-viral activity. Med Microbiol Immunol 204(6):635\u2013645","journal-title":"Med Microbiol Immunol"},{"issue":"13","key":"543_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2174\/1389450115666141027110156","volume":"15","author":"A Carrizzo","year":"2014","unstructured":"Carrizzo A, Forte M, Lembo M, Formisano L, Puca AA, Vecchione C (2014) Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases. Curr Drug Targets 15(13):1231\u20131246","journal-title":"Curr Drug Targets"},{"issue":"8","key":"543_CR48","doi-asserted-by":"publisher","first-page":"e44072","DOI":"10.1371\/journal.pone.0044072","volume":"7","author":"N Richerioux","year":"2012","unstructured":"Richerioux N, Blondeau C, Wiedemann A, Remy S, Vautherot JF, Denesvre C (2012) Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek\u2019s Disease Virus. PLoS One 7(8):e44072","journal-title":"PLoS One"},{"issue":"20","key":"543_CR49","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.1073\/pnas.0307512101","volume":"101","author":"Y Gao","year":"2004","unstructured":"Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 101(20):7618\u20137623","journal-title":"Proc Natl Acad Sci USA"},{"key":"543_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","volume":"605","author":"R Kumar","year":"2017","unstructured":"Kumar R, Sanawar R, Li X, Li F (2017) Structure, biochemistry, and biology of PAK kinases. Gene 605:20\u201331","journal-title":"Gene"},{"issue":"4","key":"543_CR51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chembiol.2008.03.005","volume":"15","author":"SW Deacon","year":"2008","unstructured":"Deacon SW, Beeser A, Fukui JA, Rennefahrt UE, Myers C, Chernoff J, Peterson JR (2008) An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 15(4):322\u2013331","journal-title":"Chem Biol"},{"issue":"5\u20136","key":"543_CR52","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000150502","volume":"39","author":"C Sinzger","year":"1996","unstructured":"Sinzger C, Jahn G (1996) Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39(5\u20136):302\u2013319","journal-title":"Intervirology"},{"issue":"1","key":"543_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0378-1119(00)00205-5","volume":"251","author":"AJ Melendez","year":"2000","unstructured":"Melendez AJ, Carlos-Dias E, Gosink M, Allen JM, Takacs L (2000) Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 251(1):19\u201326","journal-title":"Gene"},{"issue":"1","key":"543_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0005-2760(76)90053-9","volume":"424","author":"RT Huang","year":"1976","unstructured":"Huang RT (1976) Sphingolipids of influenza viruses. Biochim Biophys Acta 424(1):90\u201397","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"543_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0167-4889(91)90049-4","volume":"1095","author":"A Miccheli","year":"1991","unstructured":"Miccheli A, Ricciolini R, Lagana A, Piccolella E, Conti F (1991) Modulation of the free sphingosine levels in Epstein Barr virus transformed human B lymphocytes by phorbol dibutyrate. Biochim Biophys Acta 1095(1):90\u201392","journal-title":"Biochim Biophys Acta"},{"issue":"8\u20139","key":"543_CR56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.micinf.2010.04.007","volume":"12","author":"TC Yang","year":"2010","unstructured":"Yang TC, Lai CC, Shiu SL, Chuang PH, Tzou BC, Lin YY, Tsai FJ, Lin CW (2010) Japanese encephalitis virus down-regulates thioredoxin and induces ROS-mediated ASK1-ERK\/p38 MAPK activation in human promonocyte cells. Microbes Infect 12(8\u20139):643\u2013651","journal-title":"Microbes Infect"},{"issue":"1","key":"543_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/1535-7163.MCT-13-0466","volume":"13","author":"Z Qin","year":"2014","unstructured":"Qin Z, Dai L, Trillo-Tinoco J, Senkal C, Wang W, Reske T, Bonstaff K, Del Valle L, Rodriguez P, Flemington E, Voelkel-Johnson C, Smith CD, Ogretmen B, Parsons C (2014) Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol Cancer Ther 13(1):154\u2013164","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"543_CR58","doi-asserted-by":"publisher","first-page":"13648","DOI":"10.1074\/jbc.M807498200","volume":"284","author":"D Yamane","year":"2009","unstructured":"Yamane D, Zahoor MA, Mohamed YM, Azab W, Kato K, Tohya Y, Akashi H (2009) Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. J Biol Chem 284(20):13648\u201313659","journal-title":"J Biol Chem"},{"issue":"5","key":"543_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel S, Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4(5):397\u2013407","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5356","key":"543_CR60","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1126\/science.279.5356.1552","volume":"279","author":"MJ Lee","year":"1998","unstructured":"Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279(5356):1552\u20131555","journal-title":"Science"},{"issue":"7","key":"543_CR61","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0022034510389178","volume":"90","author":"JJ Aarthi","year":"2011","unstructured":"Aarthi JJ, Darendeliler MA, Pushparaj PN (2011) Dissecting the role of the S1P\/S1PR axis in health and disease. J Dent Res 90(7):841\u2013854","journal-title":"J Dent Res"},{"issue":"6","key":"543_CR62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nri2974","volume":"11","author":"S Spiegel","year":"2011","unstructured":"Spiegel S, Milstien S (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11(6):403\u2013415","journal-title":"Nat Rev Immunol"},{"key":"543_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2016.00167","volume":"7","author":"KV Blankenbach","year":"2016","unstructured":"Blankenbach KV, Schwalm S, Pfeilschifter J, Meyer Zu Heringdorf D (2016) Sphingosine-1-phosphate receptor-2 antagonists: therapeutic potential and potential risks. Front Pharmacol 7:167","journal-title":"Front Pharmacol"},{"key":"543_CR64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1743-422X-10-296","volume":"10","author":"S Tong","year":"2013","unstructured":"Tong S, Tian J, Wang H, Huang Z, Yu M, Sun L, Liu R, Liao M, Ning Z (2013) H9N2 avian influenza infection altered expression pattern of sphiogosine-1-phosphate receptor 1 in BALB\/c mice. Virol J 10:296","journal-title":"Virol J"},{"issue":"2","key":"543_CR65","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.yexmp.2017.09.006","volume":"103","author":"X Wang","year":"2017","unstructured":"Wang X, Yu Y, Li M, Yu Y, Liu G, Xie Y, Liu Y, Yang X, Zou Y, Ge J, Chen R (2017) Sphingosine 1-phosphate alleviates Coxsackievirus B3-induced myocarditis by increasing invariant natural killer T cells. Exp Mol Pathol 103(2):210\u2013217","journal-title":"Exp Mol Pathol"},{"key":"543_CR66","doi-asserted-by":"crossref","unstructured":"Nagahashi M, Takabe K, Terracina KP, Soma D, Hirose Y, Kobayashi T, Matsuda Y, Wakai T (2014) Sphingosine-1-phosphate transporters as targets for cancer therapy. Biomed Res Int 2014:651727","DOI":"10.1155\/2014\/651727"},{"key":"543_CR67","doi-asserted-by":"publisher","first-page":"e28318","DOI":"10.4161\/sgtp.28318","volume":"5","author":"C Broeke Van den","year":"2014","unstructured":"Van den Broeke C, Jacob T, Favoreel HW (2014) Rho\u2019ing in and out of cells: viral interactions with Rho GTPase signaling. Small GTPases 5:e28318","journal-title":"Small GTPases"},{"issue":"16","key":"543_CR68","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.1128\/JVI.00609-12","volume":"86","author":"Y Xiang","year":"2012","unstructured":"Xiang Y, Zheng K, Ju H, Wang S, Pei Y, Ding W, Chen Z, Wang Q, Qiu X, Zhong M, Zeng F, Ren Z, Qian C, Liu G, Kitazato K, Wang Y (2012) Cofilin 1-mediated biphasic F-actin dynamics of neuronal cells affect herpes simplex virus 1 infection and replication. J Virol 86(16):8440\u20138451","journal-title":"J Virol"},{"issue":"4","key":"543_CR69","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/v3040336","volume":"3","author":"KL Roberts","year":"2011","unstructured":"Roberts KL, Baines JD (2011) Actin in herpesvirus infection. Viruses 3(4):336\u2013346","journal-title":"Viruses"},{"issue":"Pt 12","key":"543_CR70","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1099\/vir.0.82231-0","volume":"87","author":"S Hoppe","year":"2006","unstructured":"Hoppe S, Schelhaas M, Jaeger V, Liebig T, Petermann P, Knebel-Morsdorf D (2006) Early herpes simplex virus type 1 infection is dependent on regulated Rac1\/Cdc42 signalling in epithelial MDCKII cells. J Gen Virol 87(Pt 12):3483\u20133494","journal-title":"J Gen Virol"},{"issue":"19","key":"543_CR71","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.1128\/JVI.00835-09","volume":"83","author":"P Petermann","year":"2009","unstructured":"Petermann P, Haase I, Knebel-Morsdorf D (2009) Impact of Rac1 and Cdc42 signaling during early herpes simplex virus type 1 infection of keratinocytes. J Virol 83(19):9759\u20139772","journal-title":"J Virol"},{"issue":"12","key":"543_CR72","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1046\/j.1365-2443.2000.00383.x","volume":"5","author":"T Murata","year":"2000","unstructured":"Murata T, Goshima F, Daikoku T, Takakuwa H, Nishiyama Y (2000) Expression of herpes simplex virus type 2 US3 affects the Cdc42\/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells 5(12):1017\u20131027","journal-title":"Genes Cells"},{"issue":"3","key":"543_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tcb.2009.12.005","volume":"20","author":"C Broeke Van den","year":"2010","unstructured":"Van den Broeke C, Radu M, Chernoff J, Favoreel HW (2010) An emerging role for p21-activated kinases (Paks) in viral infections. Trends Cell Biol 20(3):160\u2013169","journal-title":"Trends Cell Biol"},{"issue":"7","key":"543_CR74","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1128\/JVI.03107-12","volume":"87","author":"T Jacob","year":"2013","unstructured":"Jacob T, Van den Broeke C, van Troys M, Waterschoot D, Ampe C, Favoreel HW (2013) Alphaherpesviral US3 kinase induces cofilin dephosphorylation to reorganize the actin cytoskeleton. J Virol 87(7):4121\u20134126","journal-title":"J Virol"},{"issue":"1","key":"543_CR75","doi-asserted-by":"publisher","first-page":"e00958","DOI":"10.1128\/mBio.00958-13","volume":"5","author":"K Zheng","year":"2014","unstructured":"Zheng K, Xiang Y, Wang X, Wang Q, Zhong M, Wang S, Wang X, Fan J, Kitazato K, Wang Y (2014) Epidermal growth factor receptor-PI3K signaling controls cofilin activity to facilitate herpes simplex virus 1 entry into neuronal cells. MBio 5(1):e00958\u201300913","journal-title":"MBio"},{"issue":"11","key":"543_CR76","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nrm2521","volume":"9","author":"S Iden","year":"2008","unstructured":"Iden S, Collard JG (2008) Crosstalk between small GTPases and polarity proteins in cell polarization. Nat Rev Mol Cell Biol 9(11):846\u2013859","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"543_CR77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/rmv.1718","volume":"23","author":"JM Carr","year":"2013","unstructured":"Carr JM, Mahalingam S, Bonder CS, Pitson SM (2013) Sphingosine kinase 1 in viral infections. Rev Med Virol 23(2):73\u201384","journal-title":"Rev Med Virol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-018-0543-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0543-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0543-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T09:01:30Z","timestamp":1604221290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-018-0543-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":77,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1007\/s00430-018-0543-4","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"28 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicting financial or other interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}